Screening for Cancers in the Oral CAvity
Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Oct 7, 2013
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on finding oral cavity cancers, which are cancers that can occur in the mouth, among smokers aged 30 to 75 in the Somme region of France. The goal is to improve early detection since many people with oral cavity cancers are diagnosed too late, making treatment more difficult. The researchers aim to encourage general practitioners to screen for these cancers by using local resources like tobacco shops and community media to reach potential participants.
To be eligible for this study, participants must be smokers who buy cigarettes from local shops in the Somme area and must live in that region. There are no specific exclusions listed, making it easier for many to participate. If you join this trial, you can expect to be part of a program that aims to catch oral cancers early, ultimately helping improve health outcomes for smokers in your community. This is an important step in addressing the rising rates of oral cancer in the area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any smoker who buys a pack of cigarettes over a period of two weeks in a tobacco shop located on the territory of the Somme
- • lives in somme departement
- Exclusion Criteria:
- • -
About Centre Hospitalier Universitaire, Amiens
The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amiens, Picardie, France
Patients applied
Trial Officials
Bernard DEVAUCHELLE, MD, phD
Principal Investigator
Amiens University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials